Heading out to ASV 2025? Book time with our team in Montréal to discuss virus production, custom research tools, and more.
Ensure precision and reliability in your research and manufacturing with our high-fidelity solutions—shop our virus stocks and derivative products online or speak with a representative to place a custom order.
Ensure precision and reliability in your research and manufacturing with our high-fidelity solutions—shop our virus stocks and derivative products online or speak with a representative to place a custom order.
Pharma and biotech leaders trust our expertise in virus production and quality control, backed by our industry leading processes. We ensure the highest standards in virus production and quality control, delivering high-fidelity virus stocks and derivative products for consistent results. Our commitment to regulatory excellence guarantees full compliance with industry standards and industry leading transparency. With accelerated timelines, we provide scalable solutions to meet critical deadlines.
Pharma and biotech leaders trust our expertise in virus production and quality control, backed by our industry leading processes. We ensure the highest standards in virus production and quality control, delivering high-fidelity virus stocks and derivative products for consistent results. Our commitment to regulatory excellence guarantees full compliance with industry standards and industry leading transparency. With accelerated timelines, we provide scalable solutions to meet critical deadlines.
For specialized research needs, we offer on-demand production of virus stocks and derivative products, including wild-type virus strains and reporter-expressing variants. Our team can generate inactivated virus stocks, purified virus preparations, and quantified viral genetic material tailored to your specifications.
We provide purified, high-fidelity virus stocks and products that serve as the foundation for vaccine research and development. Our virus stocks are used in evaluating vaccine efficacy, immune response profiling, and viral challenge studies for seasonal and emerging infectious diseases.
Virus-based therapies are transforming cancer treatment, and our customized virus solutions facilitate groundbreaking research in oncolytic virotherapy, cancer vaccines, and immunomodulation strategies. We provide custom-designed and engineered viruses optimized for targeting tumor cells, enhancing immune responses, and evaluating novel therapeutic approaches.
Our custom virus production capabilities include production of novel viral vectors for new applications such as in vivo antibody production therapies and high-precision biomanufacturing and expression of AI-designed proteins.
Join us at the Palais des congrès de Montréal as we connect with leading virologists and biotech innovators. Our team will be available throughout the conference to discuss our reverse genetics based scalable virus production platform, and custom preclinical and clinical research solutions.
Discover how our high-fidelity virus stocks and custom-engineered viral tools are driving progress in:
Interested in a one-on-one meeting at the event?
We explore the essential role and challenges of obtaining high-fidelity viral genomic material for diagnostic assay development.
In viral diagnostic assay development—whether molecular or immunological—the quality of your reference materials can make or break your results.
We are pleased to announce our virus product pipeline. Noroviruses: Influenza viruses: Human Parainfluenza viruses: Human Metapneumoviruses: Respiratory Syncytial virus: Coronaviruses: Flaviviruses: Alphaviruses: Chimeric alphaviruses:
Subscribe to our newsletter for industry
insights and research updates.
Subscribe to our newsletter for industry
insights and research updates.